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Biohybrid structures consisting of biotinylated
glycodendrimers and proteins: inﬂuence of the
biotin ligand’s number and chemical nature on the
biotin–avidin conjugation†
Franka Ennen,ab Susanne Boye,a Albena Lederer,ab Mihaela Cernescu,c
Hartmut Komber,a Bernhard Brutschy,c Brigitte Voit*ab and Dietmar Appelhans*a
We present the bioconjugation of avidin as a central and/or bridging building block with mono-, bi- and
tetravalent biotinylated glycodendrimers to fabricate deﬁned supramolecular nanostructures for future
(bio)medical applications. For this purpose mono-, bi- and tetravalent biotinylated glycodendrimers,
decorated with short alkyl-linked or long PEG-linked biotin ligands, were synthesized and characterized
by NMR, IR and mass spectrometry and HABA displacement assay. Various techniques (UV/Vis, DLS, TEM,
LILBID-MS and AF4) were used in order to obtain information about the structural properties of diﬀerent
conjugates of avidin and mono-, bi- and tetravalent biotinylated glycodendrimers. The biotin ligand’s
spacer length, its chemical structure and the degree of biotin functionalization are essential parameters
in the formation of nanostructures with avidin having a controlled composition and size dimension up to
100 nm. Biohybrid structures with avidin as a central unit require monovalent glycodendrimers with
PEG-linked biotin, while bi- and tetravalent glycodendrimers with short alkyl-linked biotin ligands are
more eﬃcient than their counterparts with longer PEG–biotin ligands in the fabrication of deﬁned
biohybrid structures (B up to 100 nm) with avidin as a bridging unit. The most dominating key issue,
combined with other conjugation issues, is the optimal ligand–receptor stoichiometry to fabricate
biohybrid structures with diameter of <20, <30 or up to 100 nm.
Introduction
The design of versatile nanostructured biohybrid materials
has gained increasing attention over the past decades due
to their potentially extraordinary and synergetic properties
and functions. The combination of components of
synthetic and natural origins allows an applicability going
far beyond the biomedical eld including diverse matters
such as bio-sensors, articial enzymes, light harvesting
systems, photonics and nanoelectronic devices. Thus,
the formation of higher ordered molecularly organized
structures has been explored widely. These articial
supramolecular structures include solid core nanoparti-
cles, as well as linear and perfectly branched polymeric
materials.1–8
Along with other bioconjugation techniques the avidin–biotin
interaction has received great interest due to its tremendously
high, non-covalent bonding strength (Kd ¼ 10
15 M) making it a
convenient conjugation technique.9
Recently scientists have developed approaches to fabricate
dendrimer based sensory and enzymatic biohybrid structures,
but mainly attached to solid surfaces, combining the advan-
tages of dendritic structures and the strongest known non-
covalent bond.10–18
The development of intravenous formulations and the
control of release kinetics lead to the fabrication of nano-
particles (<1 mm). Small particles (<20–30 nm) are usually
eliminated by renal excretion aer administration. Since
nanoparticles can escape the circulation through so called
fenestrations of the endothelial barrier, the optimal size for
drug delivery applications in cancer research is between 70 and
200 nm and highlights the vital interest in controlled sizes of
fabricated biohybrid structures for applications in imaging and
drug and/or gene delivery.19
However, it had been found that the conjugation of polymeric
particles to avidin can enhance accumulation in tumour tissue
mediated through the EPR eﬀect due to increased molecular
weights of the associates.20,21Moreover, avidin has also the ability
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of binding to diﬀerent lectins expressed on diﬀerent cancer cell
surfaces.13,22–25 This potentially makes avidin combined with
polymeric particles a versatile building block especially in cancer
research through both passive and active targeting. A recent
study showed in an impressive manner, how a biotin-function-
alized dendron in a dendritic multi-domain delivery system can
enhance the cellular uptake of two therapeutic proteins in
mammalian cells by using streptavidin as central core units in
such a delivery system.26 Moreover, the avidin’s very high avidity
toward biotin and its lack of harmful immunogenicity27 lead to a
very high research activity conducted on avidin as a carrier for
cancer drug delivery.
On the other hand dendrimers have been proposed as ideal
candidates as supramolecular building blocks, since they are
structured by central core, branching units and high numbers
of terminal functional groups. Their unique and perfect struc-
ture oﬀers various interaction properties (e.g. encapsulation of
drugs or stabilisation of nanoparticles), whereas their periph-
eral functional groups tailor their solubility and chemical
behaviour.28,29 The high numbers of surface groups can be used
to introduce a variety of functional groups that can work as
biocompatibility mediators, enhance the blood circulation
times in drug or gene delivery vesicles (e.g. PEG terminated or
OH group terminated dendrimers),5,30 or work as recognition
moieties. Moreover, peripheral functional groups which are
considered as randomly distributed but maximally separated
substituents31–34 (e.g. alkyl or aromatic units) can act in the outer
shell of dendrimers to initiate uncontrolled/controlled self-
assembly processes. In this context certain studies in solution
revealed a signicant dependence of the biotinylated materials’
properties on the nal structure of the self-assembled nano-
structures.35–38 It seems not always appropriately address-
able14,15,35 to get suﬃcient information about the properties of
such supramolecular structures in solution. With respect to
pivotal properties (e.g. shape, size, morphology or molar
masses) of those nanostructures, the necessity for a compre-
hensive and thorough characterization has been emphasized by
various researchers recently.6,19,30,39 This led us to the conclusion
that the self-assembly of avidin with mono-, bi- and tetravalent
biotinylated dendrimers in solution (Fig. 1) still poses open
questions with respect to homogeneity of the samples,
controlled sizes and specic functions, especially with regard to
their use as dened supramolecular entities in biomedical
applications such as gene and drug delivery.
This report presents a comprehensive study of the interac-
tion of avidin with high generation (4th) dendrimers possessing
biotin ligands with varied spacer lengths, diﬀerent biotinylation
degrees in particular 1, 2 and 4 and an oligosaccharide modied
shell, which is known to possess a high biocompatibility and a
neutral surface.40,41 Thus, the successful formation of diﬀerent
biohybrid associates was identied by a variety of analytical
tools (HABA titration experiments, DLS and TEM), where
simultaneous binding events between avidin and biotinylated
macromolecules were tested. The variation in the avidin–biotin
conjugations should clarify whether avidin can be used as a
central or bridging building block. Here, we generally investi-
gated the pure conjugation solutions for exhibiting the poten-
tial use of various biotinylated poly(propylene imine) (PPI)
glycodendrimers (bGD; Fig. 2) in the fabrication of dened
biohybrid structures. A rst glance of possible biohybrid
structures using mono- and bivalent bGD is highlighted in
Fig. 1. Moreover, the investigation through novel techniques
such as asymmetrical ow eld ow fractionation (AF4) and
laser-induced liquid bead ionization/desorption mass spec-
trometry (LILBID MS) revealed further important features of the
nal compositions of those biohybrid structures. This study
may not only elucidate the formation of biohybrid structures
between avidin and biotinylated PPI glycodendrimers in the
conjugation solution, but also will give deeper insight into these
supramolecular (bio)polymeric structures from a general point
of view.
Fig. 1 Possible biohybrid structures from the theoretical point of view
when conjugating monovalent (a) and bivalent (b) biotinylated glyco-
dendrimers with avidin in deﬁned molar ratios. Those supramolecular
structures, obtained here in this study, will be directly analysed in
conjugation solution.
Fig. 2 (a) Synthesis of biotinylated glycodendrimers G4-DS-C6Bx and
G4-DS-PEG12Bx, x ¼ 1, 2 and 4: (i) conversion of PPI-G4 with a biotin
ligand and BOP in DMSO at room temperature for 2 days; biotin ligand:
biotinyl-6-aminocaproic acid (C6B) or HOOC-PEG12-biotin (PEG12B);
(ii) reductive amination of the precursor with a ratio of NH2/maltose/
BH3$Pyr of 1/20/20 in sodium borate solution at 50
C for 7 days
followed by dialysis in distilled water; the details of themolar ratios can
be seen in Table 2; (b) overview of ﬁnal compounds.
1324 | Polym. Chem., 2014, 5, 1323–1339 This journal is © The Royal Society of Chemistry 2014
Polymer Chemistry Paper
Pu
bl
ish
ed
 o
n 
17
 O
ct
ob
er
 2
01
3.
 D
ow
nl
oa
de
d 
by
 S
LU
B 
D
RE
SD
EN
 o
n 
11
/4
/2
01
9 
12
:4
1:
36
 P
M
. 
View Article Online
Results and discussion
Synthesis and characterization of biotinylated
glycodendrimers
The general strategy for the synthesis of biotinylated glycoden-
drimers with a dense maltose shell is shown in Fig. 2. In partic-
ular, the following biotinylated 4th generation glycodendrimers‡
with a dense maltose shell (G4-DS) were synthesized, character-
ized (Table 1) and used in our study: non-biotinylated G4-DS as a
reference, G4-DS-C6B1 mono-functionalized with a C6-linked
biotin, G4-DS-C6B2 di-functionalized with a C6-linked biotin,
G4-DS-C6B4 tetra-functionalized with a C6-linked biotin, G4-DS-
PEG12B1 mono-functionalized with a PEG12-linked biotin, G4-
DS-PEG12B2 di-functionalized with a PEG12-linked biotin and
G4-DS-PEG12B4 tetra-functionalized with a PEG12-linked biotin.
To functionalize the PPI-G4 scaﬀold (64 peripheral amino
groups) the dendrimers were converted either with 6-(N-bio-
tinylamino)caproic acid (C6B) or biotin-PEG12-COOH (PEG12B),
benzotriazole-1-yl-oxy-tris-(dimethylamino)-phosphonium hexa-
uorophosphate (BOP) and an excess of triethylamine in the
rst step. In the second step of the synthesis the remaining
primary amino groups were preferentially disubstituted with
maltose using a 20 fold excess of maltose monohydrate in
borate buﬀer in the presence of BH3$Pyr in a reductive amina-
tion step. Biotinylated precursors and glycodendrimers were
characterized and identied by NMR spectroscopy, IR spec-
troscopy, mass spectrometry and HABA displacement assay.
Key characteristic steps have been the biotin ligand coupling
on the PPI dendrimer surface and the determination of
the average number of biotin ligands coupled to each glycoden-
drimer, while the nal molar mass of biotinylated glycoden-
drimers was easily available through LILBID-MS (Table 1).
Both the precursors and the glycodendrimers were charac-
terized by 1H NMR spectroscopy. Exemplarily, Fig. 3a depicts
the spectrum of precursor G4-PEG12B2 with signal assignment.
A doublet at 2.75 ppm indicates that a small amount of PPI-
bonded hexamethylphosphoramide is formed in a side-reaction
Table 1 Characteristics of biotinylated glycodendrimers and their precursors; Mal ¼ maltose
Biotinylated
glycodendrimer (bGD) Liganda
Biotin determination LILBID-MS Precursor
Number of ligandsb Mobserved in g mol
1 Number of Mal M in g mol1
G4-DS — 0 46 900c 122 (128)e G4 7168g
G4-DS-C6B1 C6B (1) 1.1 46 000c 118 (126)e G4-C6B1 7500h
G4-DS-C6B2 C6B (2) 2.1 46 100c 117 (124)e G4-C6B2 7850h
G4-DS-C6B4 C6B (4) 3.6 47 650c 120 (120)e G4-C6B4 8500h
G4-DS-PEG12B1 PEG12B (1) 1.1 45 900c 116 (126)e G4-PEG12B1 8000h
G4-DS-PEG12B2 PEG12B (2) 2.0 45 700c 113 (124)e G4-PEG12B2 8820h
G4-DS-PEG12B4 PEG12B (4) 4.2 43 750d 102 (120)f G4-PEG12B4 10 500h
a Number in brackets represents the theoretical number of biotin ligands attached to the corresponding G4 scaﬀolds. b Number of biotin ligands
was determined by the avidin-40-hydroxyazobenzene-2-carboxylic acid (HABA) complex using a specic activity of avidin of 13.6 units per mg.
c Determined by LILBID MS. d Calculated by 1H NMR based on the number of biotin groups (cf. b). e Number of maltose units determined
through LILBID-MS. f M is used for estimating the number of maltose units of the glycodendrimers as described in the literature.41 g M was
determined by MALDI-TOF mass spectrometry. Results from mass determination conrm the molar mass data of G4 obtained by the company
SyMOChem (Eindhoven, The Netherlands). h M was determined by Mn of PPI-G4 and the degree of biotin substitution.
Fig. 3 1H NMR spectrum (a) of G4-PEG12B2 and (b) of G4-DS-
PEG12B2 (solvent: D2O). The signals of the biotin ligand PEG12B and of
the PPI-G4 core are assigned in (a). Maltosylation results in additional
broad signals which are shown in (b). Arrows point to ligand signals
well observable also after maltosylation (# hexamethylphosphoramide
derivative).
‡ Following suggestion from D.A. Tomalia and M. Rookmaker for
“Poly(propyleneimine) Dendrimers” in Polymer Data Handbook,42 the
nomenclature for Tomalia-type PAMAM dendrimers and other can be adopted
also for PPI dendrimers. This means that the commercially available 5th
generation PPI dendrimer, used here in this study, is a 4th generation.
This journal is © The Royal Society of Chemistry 2014 Polym. Chem., 2014, 5, 1323–1339 | 1325
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most probably due to the rather large excess of BOP applied for
complete conversion of the ligand. A correct calculation of the
number of ligands from signal integrals is hampered by signal
overlap of the ligand and PPI core signals of the precursors.
With the reasonable assumption that one equivalent of the
ligand is completely converted in the presence of a 64-fold
excess of amino end groups, a comparison of the spectra using
PPI signals as an intensity reference (in Fig. ESI-3†) conrms the
substitution of the biotin ligands in an approximately 1 : 1 and
1 : 2 ratio for -B1 and -B2 precursors, respectively. Aer malto-
sylation only few but characteristic ligand signals can be well
observed (Fig. 3b) proving the functionalization of the glyco-
dendrimer G4-DS-PEG12B2 also aer this reaction step.
Additionally to the NMR study, the number of bound biotin
ligands on each glycodendrimer was determined by HABA
displacement titration experiments according to the literature43
(Fig. 4). The average number of bound biotin ligands on the
dendritic glycosurface is summarized in Table 1. In most cases
the theoretically required number of biotin ligands coupled to
each glycodendrimer was evaluated. Interestingly, non-bio-
tinylated G4-DS shows also a replacement of the azo dye, but the
lack of a clear endpoint indicates no specic interaction and a
dissociation constant in the range of 109 to 106 M.7 In
context of the latter, it has been shown that only a pretreatment
of (strept-)avidin with a high excess of pure maltose leads to a
signicant inhibition of the (strept-)avidin–biotin interaction
where an unexpected interaction of maltose units in the binding
pockets in (strep-)avidin can be assumed.44 In our study, we can
probably exclude such a binding event between maltose units
and binding pockets of avidin due to the high amount of
chemically attached maltose units on the dendritic PPI scaﬀold.
Knowing the average number of biotin ligands on each gly-
codendrimer surface and molar mass of biotinylated glyco-
dendrimers we were able to start our study for fabricating and
characterizing the various biohybrid structures mentioned
below.
Interaction of mono- and bivalent biotinylated
glycodendrimers with avidin
The coupling of the biotinylated glycodendrimers (bGD) to
avidin as a central and bridging building block led to nano-
meter-sized biohybrid structures with potential functionalities.
Their schematic illustration is presented in Fig. 1. For the DLS
study of the formed biohybrid structures avidin was converted
with stoichiometric amounts of the (non-)biotinylated glyco-
dendrimers: G4-DS (1 and 3 equivalents (eq.)) (Fig. ESI-8†),
G4-DS-PEG12B1 (1–4 eq.) and G4-DS-C6B1 (1–4 eq.) as well as
G4-DS-PEG12B2 (0.5, 1 or 1.5 eq.) and G4-DS-C6B2 (0.5, 1 or
1.5 eq.) in the presence of 1 equivalent avidin (Fig. 5 and
Table 2). Generally, all conjugation solutions for the used C6B1,
C6B2, C6B4, PEG12B1, PEG12B2 and PEG12B4 ligands in this
study have a total mass concentration of about 0.6–0.7 mgmL1
and no precipitation was observed in all cases. In the case of the
bi- and tetravalent bGD we aimed to probe the conjugation
potential of the bGD when avidin is in excess, avidin and bGD
are equimolar or bGD is in excess.
Two general points can be identied aer the formation of
the various biohybrid structures: increasing the stoichiometric
amount of bGD against avidin obviously results in growth of the
nal biohybrid structures (Fig. 5, le panel). This growth is
accompanied by a decrease in the absorbance of complexed
HABA in the binding pockets of avidin at 500 nm in the HABA
displacement assays (Fig. 5, middle panel). Avidin and almost
all bGDs possess diameters of about 5–6 nm as the starting
point for evaluating the biohybrid structures.
Considering the biohybrid structure with avidin as a poten-
tial central building block (Fig. 5a) with monovalent bGD G4-
DS-C6B1, a general decrease in the A500nm absorbance can be
observed for all avidin–G4-DS-C6B1 associates with molar ratios
from 1/1 up to 1/4. Contrary to that the DLS data show only
increasing sizes up to a ratio of 1/3 (Fig. 5a, molar ratio 1/1 to
1/4; B 12 nm determined as peak maximum (volume (vol)%)
aer 24 h for the 1/3 and 1/4 ratios by DLS). For this conjugation
between avidin and increasing numbers of the biotin ligand
C6B, the size growth to larger biohybrid structures is obviously
hampered by the shielding properties of the densemaltose shell
where the biotin ligand C6B is surrounded by larger maltose
units in the outer shell of G4-DS-C6B1. This means that C6B is
too short and not apparent in a suﬃcient amount in the desired
conjugation step to overcome the hampering eﬀect of the dense
maltose shell. Moreover, the required length of 0.9 nm (ref. 45)
of the biotin ligand C6B in G4-DS-C6B1 to reach the avidin
binding site is not apparent. In contrast to that a suﬃcient
spacer length is given in the case of the biotin ligand PEG12B in
Fig. 4 HABA displacement assay: titration of a preformed avidin–HABA complex with left panel: G4-DS-PEG12Bx (xtheoretical ¼ 1, 2 and 4) and
right panel: G4-DS-C6Bx (xtheoretical ¼ 1, 2 and 4) as well as G4-DS and biotin as references.
1326 | Polym. Chem., 2014, 5, 1323–1339 This journal is © The Royal Society of Chemistry 2014
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G4-DS-PEG12B1 allowing the compensation of the shielding
eﬀect of the dense maltose shell. This leads to a homogeneous
increase in size with increasing amounts of the G4-DS-PEG12B1
sample against avidin (molar ratio 1/1 to 1/4, Fig. 5d – B 18 nm
determined as peakmaximum (volume (vol)%) aer 24 h for the
1/4 ratio by DLS).
The next step was to consider the biohybrid structures with
avidin as a potential bridging unit (Fig. 1b), which requires
functionalization with at least 2 biotin ligands in bGD (G4-DS-
C6B2 and G4-DS-PEG12B2; Fig. 5g and j). This higher function-
alization should naturally increase the probability of occupied
avidin binding sites by both biotin ligands, C6B and PEG12B. For
example, a molar ratio of 1/1 between avidin and G4-DS-C6B2
(Fig. 5g) results in a larger biohybrid structure size in comparison
with those of G4-DS-C6B1 (Fig. 5a). Indeed, the conversion of
avidin with G4-DS-C6B2 (Fig. 5g) or G4-DS-PEG12B2 (Fig. 5j)
shows in both cases an increase in size upon addition of
increasing amounts of bGD. The avidin–G4-DS-C6B2 associates
Fig. 5 Left panel: DLS results of the conversions of avidin with biotinylated glycodendrimers, middle panel: corresponding HABA displacement
assay results, right panel: (c) TEM images of avidin and G4-DS-C6B2 1/1, (f) TEM size measurements: particle size distribution of avidin–G4-DS-
C6B2 1/1; (i) TEM image of avidin and G4-DS-PEG12B2 1/1, (l) TEM size measurements: particle size distribution of avidin–G4-DS-PEG12B2 1/1.
This journal is © The Royal Society of Chemistry 2014 Polym. Chem., 2014, 5, 1323–1339 | 1327
Paper Polymer Chemistry
Pu
bl
ish
ed
 o
n 
17
 O
ct
ob
er
 2
01
3.
 D
ow
nl
oa
de
d 
by
 S
LU
B 
D
RE
SD
EN
 o
n 
11
/4
/2
01
9 
12
:4
1:
36
 P
M
. 
View Article Online
show diameters up to B 28 nm determined as peak maximum
(volume (vol)%) aer 24 h for the 1/1.5 ratio by DLS (Fig. 5g –
molar ratio 1/0.5; 1/1; 1/1.5). In contrast the G4-DS-PEG12B2-
based associates provide diameters up to B 17 nm aer 24 h
(Fig. 5j, DLS – molar ratio 1/0.5; 1/1; 1/1.5 with increasing G4-DS-
PEG12B2).
This surprising result from the G4-DS-PEG12B2 conjugation
step can be explained by interfering interactions of the PEG
chains between G4-DS-PEG12B2 macromolecules as well as
undesired non-specic interactions of PEG chains with the
glycoprotein avidin during the avidin–biotin conjugation.
Although PEG is generally known for its protein repellent
properties, it has been reported that PEG does interact with
certain proteins such as mucin,46 lysozyme47,48 or bovine serum
albumin.48 However, either repellent or non-repellent interac-
tions of PEG with proteins are critically dependent on various
factors such as the amount of PEG chains on the surface, their
length, the protein conformation properties or the presence of
certain amino acids.37,38,46,47,49
To further clarify the eﬃciency of PEG12B2 ligands the non-
homogenous solution was exemplarily ltered by the hollow
bre ltration method to separate non-conjugated bGD from
biohybrid structures aer the conjugation step between G4-DS-
PEG12B2 and avidin with 1/1 molar ratio (Fig. 6). Aer this
purication process the average diameter of these dendritic
supramolecular structures is about 20 nm, while the non-
homogenous solution aer the conjugation process shows an
average diameter of about 13 nm for the conjugates (Table 2).
This additional purication step impressively shows us that a
successful separation of non-conjugated bGD and avidin from
the desired biohybrid structures is possible. This rst purica-
tion result oﬀers us the chance in the future to obtain purer
biohybrid structures more suitable for biomedical applications.
Analysing the results from the TEM images of the various
biohybrid structures of PEG12B1 with 1/1 and 1/3 molar ratios
(Fig. ESI-9†), C6B2 with 1/1 molar ratio (Fig. 5c and f) and
PEG12B2 with 1/1 molar ratio (Fig. 5i and l), one can recognize
two tendencies: rstly, PEG12B1 biohybrid structures strongly
tend to aggregate into spherical particles with diameters
between 25 and 40 nm. In contrast to that, biohybrid structures
obtained from G4-DS-C6B2 and G4-DS-PEG12B2 with 1/1 molar
ratio to avidin outline diameters in the range of 18 and 25 nm.
On the one hand one has to take into account that the TEM
images show particles in the dry state, which may be partly
distorted due to the evaporation of the solvent. This lead to
diﬀerent kinds of aggregated (PEG12B1) and non-aggregated
(PEG12B2 and C6B2) biohybrid structures in our study.
Furthermore, compared to the DLS study decreased buﬀer
molarity and increased total concentrations were used in the
TEM study in order to ensure the imaging of the supramolecular
organizations. On the other hand it has to be considered that
DLS size curves present certain size distribution. If there are
populations present that diﬀer only in a few nanometers in their
sizes, one will measure the overlap of the sizes of these pop-
ulations e.g. avidin and/or bGD and formed associates. The
higher the amount of non-conjugated biotinylated glycoden-
drimer, the lower are the mean diameters of biohybrid struc-
tures (e.g. Fig. 5a and g). This point was impressively conrmed
by the purication step of G4-DS-PEG12B2 biohybrid structures
with 1/1 molar ratio (Fig. 5g and 6b) allowing for the separation
of non-conjugated components. Now, the nal diameter of the
puried biohybrid structures from the DLS study (Fig. 6) nicely
Table 2 Overview of mean diameters (d) of avidin, bGDs and bio-
conjugates measured after 1 day taken from the volume distribution
Sample name PdI d (V%)/nm V%
Avidina 0.27 7.9 100
G4-DS-C6B1a 0.338 5.9 100
1/1 0.235 8.1 100
1/2 0.24 11.1 100
1/3 0.228 13.3 100
1/4 0.273 11.6 100
G4-DS-C6B2a 0.34 6.1 100
1/0.5 0.261 9.6 100
1/1 0.216 14.6 100
1/1.5 0.169 28.4 100
G4-DS-PEG12B1a 0.355 5.6 100
1/1 0.224 9.1 100
1/2 0.221 10.7 100
1/3 0.204 13.1 100
1/4 0.165 17.9 100
G4-DS-PEG12B2a 0.375 6.0 100
1/0.5 0.341 9.9 100
1/1 0.222 12.7 100
1/1.5 0.18 16.7 100
G4-DS-C6B4a 0.284 5.6 100
1/0.5 0.2 30.2 100
1/1 0.138 48.6 100
1/1.5 0.231 20.0 100
G4-DS-PEG12B4a 0.43 6.1 100
1/0.5 0.16 40.5 100
1/1 0.184 39.9 100
1/1.5 0.246 20.9 100
a Samples were only measured aer 1 day.
Fig. 6 Measured diameters of supramolecular organizations of avidin
with G4-DS-PEG12B2 1/1 puriﬁed through hollow ﬁbre ﬁltration. (a)
Increasing resulting diameters with increasing puriﬁcation time; (b)
comparison of the diameter of the removed particles (B 8 nm, DLS
volume distribution), the initial compositions (B 13 nm, DLS volume
distribution) and the resulting particle composition (B 20 nm, DLS
volume distribution).
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matches the average diameter obtained from the TEM study
(Fig. 5l). Thus, there is a good correlation in this specic
example (Fig. 5i, l and 6), while the larger detectable diameters
from the DLS study in the case of C6B2 with 1/1 molar ratio
(Fig. 5g) and PEG12B2 with 1/1 molar ratio (Fig. 5j) also pref-
erentially match the mean diameters evaluated by the TEM
study (Fig. 5f and l) when excluding the lowering eﬀects of non-
conjugated components.
The results from the DLS study have been supported by
estimating the apparently bound amount of bGD to avidin. A
linear regression of the lower part of the titration curve (cf.
Fig. 4) and the change in absorbances in the HABA displace-
ment assays (Fig. 5b, e, h and k) were used to determine the
amount of displaced dye and the amount of bound bGD,
respectively. The determined apparent values compared to the
initial molar ratios are summarized in Table 3. It revealed that
in most samples only about one half of the bGD are bound to
avidin. This seems surprising, since avidin–biotin conjugation
is characterized by a very low dissociation constant of 1015 M.
The much lower binding strength of mono- and bivalent
bGD against avidin is preferentially explainable when consid-
ering the structural properties of avidin and bGD and the dis-
cussed conjugation mechanism of biotin on the avidin binding
sites: rstly, it is inuenced by a sterical shielding eﬀect of bGD
(Fig. 7c) when they are coupled to the avidin binding site. This is
supported by (A) the binding of about 50% of bGD to the avidin
scaﬀold (Table 3) and smaller mean diameters (DLS study)
inuenced by non-conjugated bGD and (B) similar diameters of
avidin and bGD of about 5–6 nm. For better understanding the
lower binding strength of bGD against avidin, the structural
dimensions of avidin with its binding sites are simplied,50,51
presented in Fig. 7a. Moreover, it was shown by spin-labelled
biotin derivatives that those were initially bound in a random
fashion and changed slowly from a possible cis position to a
more favoured trans position on the avidin binding sites
(Fig. 7b).50 This kind of rearrangement of biotin derivatives was
also discussed by Kisak et al.52 and Connolly et al.53 Thus, it can
be proposed that the conjugation mechanism for binding bGD
on avidin binding sites takes place in the same fashion as
postulated for much larger and equally sized biotin derivatives.
With this in mind the formation of (larger) biohybrid structures
with avidin as central and bridging units (Fig. 5) is accompanied
by (A) permanently occurring association and dissociation
processes with respect to cis–trans rearrangement of biotin
derivatives on avidin binding sites (Fig. 7b), and (B) perma-
nently apparent sterical demands of bGD preferentially pre-
venting the conjugation of a third and fourth bGD on avidin
binding sites (Fig. 7c). Finally, in the case of G4-DS-C6B1 with
1/2, 1/3 and 1/4molar ratios similar mean diameters between 11
and 13 nm (Table 2) can be found while an increased release of
HABA molecules is observable (Table 3). This implies that even
more simultaneous association–dissociation steps of G4-DS-
C6B1 against avidin take place and the resulting binding of G4-
DS-C6B1 on avidin binding sites is weak due to reasonable
points (sterical demands, spacer length, etc.). Thus, in the 1/4
conjugation solution even more non-conjugated bGD and
avidin, respectively, are responsible for lowering the mean
diameter in comparison to 1/3 conjugation solution (Table 2).
However, a lack of complete conversion of avidin with bis-
biotinyl-functionalized alkanes was also reported by Green
et al.45 In order to further evaluate the size determining key
factors for fabricating dened biohybrid structures, bGD with
four biotin ligands C6B and PEG12B (G4-DS-C6B4 and G4-DS-
PG12B4) have been used to investigate their conjugation
potential with avidin.
Interaction of tetravalent biotinylated glycodendrimers with
avidin
While biohybrid structures with a maximal diameter of 30 nm
are available in the case of the G4-DS-C6B2 conjugation step
(Fig. 5g and Table 2), G4-DS-C6B4 and G4-DS-PG12B4, pos-
sessing 4 biotin ligands, produce nanoparticles of up to 100 nm
in diameter. This result was determined by usingmolar ratios of
1/0.5, 1/1 and 1/1.5 for fabricating avidin–bGD associates
(Fig. 8) of diﬀerent sizes along with evaluating the peak maxima
by DLS (Tables 2 and 4).
One can impressively identify diﬀerent conjugation behav-
iours of both bGD against avidin macromolecules mainly trig-
gered by the type of biotin ligand. The size distributions of the
Table 3 Summary of initial avidin–bGD stoichiometry and bound
glycodendrimer in the biohybrid structure for G4-DS-C6B1, G4-DS-
C6B2, G4-DS-PEG12B1, and G4-DS-PEG12B2
Avidin–bGD Initial molar ratio Bound GDa
Avidin–G4-DS-C6B1 1/1 0.49
1/2 0.99
1/3 1.47
1/4 1.92
Avidin–G4-DS-C6B2 1/0.5 0.35
1/1 0.53
1/1.5 0.87
Avidin–G4-DS-PEG12B1 1/1 0.50
1/2 0.97
1/3 1.49
1/4 2.04
Avidin–G4-DS-PEG12B2 1/0.5 0.31
1/1 0.50
1/1.5 0.75
a Based on the amount of HABA displaced by biotin ligands.
Fig. 7 (a) Structure and dimensions of avidin;50,51 (b) assumed favoured
coupling of two bGD as proposed by Sinha et al.;50 (c) sterical shielding
eﬀect of the coupled glycodendrimers due to similar sizes of avidin
and the bGD.
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established biohybrid structures appeared broad and had a
bimodal behaviour only in the case ofG4-DS-PEG12B4 aer 24 h
(Fig. 8a and c). Aer 7 days the dispersity remains entirely stable
(compare Tables 2 and 4) but the initial bimodal size distribu-
tion also completely disappeared (Fig. 8d; avidin–G4-DS-
PEG12B4 with a molar ratio of 1/1).
Results from Fig. 8 and Table 4 also show that the ratio 1/1 of
avidin–G4-DS-C6B4 induced the formation of large aggregates
of diameters up to more than 100 nm and of average diameters
of about 50 nm. Compared to that the interaction ratio 1/0.5 of
avidin–G4-DS-PEG12B4 seems to reach aggregates with the
highest diameters (B 40 nm) which are in the same size range as
those obtained by the 1/1 interaction ratio (Fig. 8b and Table 4).
Furthermore, applying increasing ratios (1/0.5 and 1/1) for
biohybrid structures with G4-DS-C6B4 one can nd increasing
diameters for the aggregates. The UV/Vis experiments between
G4-DS-C6B4 and HABA–avidin complexes conrmed the fact of
increasing diameters as well since the increasing release of
HABA molecules from HABA–avidin complexes was determined
(Table ESI-2†). Finally, a surprising tendency is recognizable
where the smallest biohybrid structures (B20 nm) are formed
by applying excess of tetravalent bGD (Fig. 8). This is also
accompanied by the equal/highest release of the azo dye HABA
from HABA–avidin complexes in comparison with those with
other conjugation ratios (Tables ESI-2 and 3†).
Overall, we cannot postulate “the higher the diameters of
biohybrid structures, the higher is the release of HABA molecules
from HABA–avidin complexes” as found in the case of the bio-
hybrid structure with bivalent bGD (Tables 2 and 3). This point is
only observable in the case of GD-G4-DS-C6B4 up to molar ratio
1/1 against avidin (Table 4, ESI-2 and 3†). In all other conjugation
steps similar and excess tetravalent bGD with molar ratios of 1/1
and 1/1.5 against avidin result in the same or decreased diameters
of the biohybrid structures. This can be explained by the following
points, afore-mentioned in the discussion of mono- and bivalent
bGD: (I) association and dissociation of tetravalent bGD on avidin
binding sites and/or (II) the fast saturation of the binding pockets
of avidin by excess biotin ligands in the conjugation mixture can
lead to smaller conjugated avidin–bGD structures where dissoci-
ation steps are partly favoured. Due to shielding eﬀects of bGD
and weak binding strengths between avidin and bGD one can
Fig. 8 DLS results of conversions of avidin with G4-DS-C6B4 (a) after 1 day and (c) after 7 days and with G4-DS-PEG12B4 (b) after 1 day and (d)
after 7 days.
Table 4 Overview of mean diameters of avidin, tetravalent bio-
tinylated glycodendrimers and bioconjugates measured after 7 days
taken from the volume distribution
Sample name PdI d (V%)/nm V%
Avidina 0.27 7.9 100
G4-DS-C6B4a 0.284 5.6 100
1/0.5 0.164 40.2 100
1/1 0.145 57.1 100
1/1.5 0.201 22.0 100
G4-DS-PEG12B4a 0.43 6.1 100
1/0.5 0.155 43.3 100
1/1 0.171 41.5 100
1/1.5 0.241 24.3 100
a Samples were only measured aer 1 day.
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assume highly repeating association and dissociation steps in the
conjugation of tetravalent bGD against avidin that result in the
higher release of HABA molecules from the HABA–avidin
complexes (Tables ESI-2 and 3†). In such dynamic processes a
hampered re-association of the azo dye HABA to the avidin
binding site can be supposed.
Theoretical binding calculation models in the future may
give answer to be sure about the right number of biotins bound
to the avidin macromolecules in the biohybrid structures as
summarized in the Tables 2, 4, ESI-2 and ESI-3.† From the
experimental point of view using only the HABA displacement
assay for assessment gives some limitations for deeper expla-
nation. Moreover, the work by Green et al. in the early 1970s
gave an indication that in the presence of a higher number of
biotin ligands a depolymerisation step, meaning a dissociation
process between avidin and biotin ligands, could take place.45
Summarizing the results ofG4-DS-C6B4 and G4-DS-PEG12B4
bioconjugation with avidin, we can state that there is an optimal
molar interaction ratio for both types of bGD to fabricate
monomodal biohybrid structures with large dimensions of up
to 100 nm, and G4-DS-C6B4 exhibits a slightly higher bio-
conjugation eﬃciency than G4-DS-PEG12B4.
Overall one can conclude the following key factors for fabri-
cating biohybrid structures with avidin as a potential bridging
unit and mono-, bi- and tetravalent bGD (see also Fig. 9):
(I) In the case of the monovalent bGD the PEG12B ligand is
more eﬃcient than the C6B ligand due to its more accessible
nature (Table 2). Moreover, the combination of spacer length
dependency with sterical demand of bGD plays here the
deciding role in this specic conjugation case (Fig. 7c). Along
with these observations, examples from the literature indicate
that dendrons with biotin ligands attached at the focal side may
imply a better availability against the binding pockets of avidin
to design and fabricate small bioconjugates with avidin as a
central unit.15,26 Despite this it gives no further eﬀorts to eval-
uate the molar masses of those biohybrid structures.
(II) Bivalent bGD fabricate biohybrid structures with diam-
eters up to 30 nm (Table 2), where G4-DS-C6B2 is more eﬃcient
than G4-DS-PEG12B2. In this context one would expect larger
dimensions of the biohybrid structures that bivalent bGD can
act as a linear unit against avidin. Due to the randomly
distributed biotin ligands, but maximally separated31 on the
surface of the glycodendrimers, it even gives some sterical
prevention due to the sterical demand of the bGD to undergo
the expected biotin–avidin conjugation for this molecular
composition. This means that the most eﬃcient spatial
arrangement of the two biotin ligands would be 180 on a
spherical dendritic PPI scaﬀold in G4-DS-C6B2 and G4-DS-
PEG12B2 in order to fabricate biohybrid structures through the
polymerization of the bivalent bGD and avidin. Moreover this
might be also a question of spacer length as Green et al. showed
in 1971,45 where the distance between the biotin moieties and
hence the length of the hydrophobic linker direct the degree of
polymerization of avidin.
(III) Increasing the average number of biotin ligands from 2
up to 4 in bGD results in the fabrication of biohybrid structures
with dimensions in the range of 20–150 nm (Fig. 8).
(IV) A higher degree of biotin functionalization increases the
probability of avidin–biotin conjugation and enables a
compensation of the lack of a required spacer length of the
C6Bx (x ¼ 2 and 4). Surprisingly, this leads in the cases of the
bivalent and tetravalent biotinylated GDs G4-DS-C6B2 and
G4-DS-C6B4 to a slightly higher conjugation eﬃciency
compared to the PEG12Bx (x ¼ 2 and 4) and hence to higher
sizes of the nal biohybrid structures.
Along with this observation it gives a general conjugation
behaviour known from the literature that the inuence
of longer polymer chains on the non-conjugation step
between avidin and biotin-end-functionalized PEG chains
increases.37,38 Finally, from our and other studies15,26,36–38 one
can conclude that the structural composition of biotin func-
tionalized (macro-)molecules also plays an important role in
the design and fabrication of biotin–avidin conjugates con-
taining supramolecular structures.
(V) The molar interaction ratio is one dominating key factor
to tailor the size of the desired biohybrid structures besides the
biotin ligand numbers in bGD. We could demonstrate that
there exists an optimal molar interaction ratio for each
component pair for fabricating dened biohybrid structures.
The latter conclusion was also drawn from the investigation of
the binding of biotin-functionalized liposomes or gold nano-
particles to streptavidin molecules.52,53
(VI) To the best of our knowledge, no further dendritic
example is presented, where multivalent biotinylated den-
drimers or hyperbranched polymers were used to evaluate the
fabrication of larger supramolecular structures with dened
diameters by using (strept)avidin–biotin conjugation steps in
solution as known from other prominent non-covalent conju-
gation steps such as adamantane-b-cyclodextrin54,55 or ada-
mantane–azobenzene host–guest interactions on dendritic
surfaces.56
(VII) Finally, the fabrication of biohybrid structures with
diﬀerent diameters is completely accompanied by intra- and
intermolecular association and dissociation processes (Fig. 7)
until achieving nal diameters. Using specic combination of
degree of biotinylation on the glycodendrimer surface (4 biotin
ligands) and dened ligand–receptor stoichiometry (1/1 or 1/1.5
molar ratios) dissociation and depolymerisation processes
mainly occur that exhibit the same and smaller diameters of the
biohybrid structures in contrast to optimal conjugation condi-
tions (Tables 2 and 4).
AF4 study versus LILBID MS study on biohybrid structure
formation with 1 and 3 equivalents of G4-DS-C6B1
For the estimation of the molar mass distributions of the single
components and their associates two diﬀerent techniques have
been applied, the Laser-Induced Liquid Bead Ion/Desorption
Mass Spectrometry (LILBID-MS)57–59 and the Asymmetrical Flow
Field Flow Fractionation (AF4).60–63 Both of them are quite novel
methods and their application on biological and biomimetic64,65
samples have been developed recently.
The molar mass of biohybrid structures formed by the
conversion of 1 or 4 equivalents G4-DS-C6B1 against 1 equivalent
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of avidin was determined by LILBIDMS. Fig. 10a showsmainly 1/1
and 1/2 complexes next to free G4-DS-C6B1 and avidin. This
seems reasonable considering the amount of bound bGD
(Table 3) and the stagnation in sizes as found by the DLS studies
(Fig. 5a). However, even a higher amount of bGD of 4 equivalents
against avidin does not lead to a formation of 1/3 adducts of
avidin and bGD supporting our explanations to Fig. 7 and also the
hypothesis of sterical induced stoichiometry based on the nd-
ings of Tomalia et al.66–68
Additionally, the molar mass distributions of selected bio-
conjugates were determined by asymmetrical ow eld ow
fractionation (AF4). In our study the nal compositions of the
solutions were analysed qualitatively and quantitatively using
initial molar ratios of avidin–G4-DS-C6B1 of 1/1 and 1/3. The
AF4 results from avidin–G4-DS-C6B1 with the molar ratio of 1/1
mainly show free glycodendrimer and free avidin next to the
presence of a minor amount of biohybrid structures (Fig. 11a
and b and Table 5).
As revealed by the DLS study, there is a lower probability for
the glycodendrimer with one C6B ligand to undergo the desired
avidin–biotin conjugation. The results (Fig. 11c and d and
Table 5) from the molar ratio of 1/3 for avidin–G4-DS-C6B1
revealed, however, the formation of the desired bioconjugates
next to few free glycodendrimers. Molar masses of about
170 kDa for the bioconjugates (Table 5) indicate the presence of
a 1/2 complex rather than a 1/3 complex. This is in agreement
with the LILBID-MS data (Fig. 10b) discussed above.
Molar masses of the single components were determined
(Table 6) before studying the fabrication of desired biohybrid
structures between G4-DS-C6B1 and avidin. Furthermore, non-
biotinylated G4-DS was used to optimize the handling of dense
shell glycodendrimers in this AF4 study.
Both the molecular and supramolecular structure distribu-
tions of the biohybrid structures G4-DS-C6B1 and avidin were
characterized by AF4 (Fig. 11). In the case of the 1/1 ratio of the
components we identied free dendrimer, free avidin, the
preferred 1/1 bioconjugate and complex nanostructures of
them. In the case of the 1/3 ratio, a complete conversion of
avidin was identied, while the bioconjugates in 1/2 stoichi-
ometry were mainly determined and not the expected bio-
conjugates in 1/3 stoichiometry. However, along with the
LILBID-MS results a shoulder of the minor 1/1 complex (Fig. 11:
Fig. 10 LILBID-MS spectra of (a) avidin–G4-DS-C6B1 as 1/1 ratio and
(b) avidin–G4-DS-C6B1 as 1/4 after 24 h.
Fig. 9 Summary of the present study for fabricating diﬀerent nanometer-sized biohybrid structures after 1 day determined by degree of bio-
tinylation on the glycodendrimer surface and deﬁned ligand–receptor stoichiometries. Short ligand C6B or long ligand PEG12B on bGD were
used for avidin–biotin conjugation.
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17–18 min) can be observed but was not analysed to prevent
unnecessarily complicated analyses. This is in accordance with
the results from DLS, which showed stagnation in sizes for a
molar ratio of 1/3. Additionally certain amounts of higher
molecular weight associates (denoted as nanostructures) were
found. Their appearance in the AF4 fractograms could be a
result of the focusing conditions of the separation technique.
This eﬀect is the subject of a recent investigation and will be
discussed in a forthcoming paper.
In summary AF4 show as well that no complete conversion
for 1/1 and 1/3 molar ratios took place where single components
(bGD and avidin) of the conversion steps were evaluated
(Table 5). Despite the fact of hampered avidin–biotin conjuga-
tion of the bGD to avidin as previously discussed an additional
explanation could be the fact that the non-biotinylated glyco-
dendrimer in the bGD sample is present in the dendrimer
mixture as a result of statistical distribution of the biotin units
aer the modication of PPI-G4 (Fig. 2). Another point is the
decreased conjugation eﬃciency of the bGD due to sterical
reasons as discussed above. This eﬀect was also found in the
Fig. 11 AF4 results for the conversion of avidin with G4-DS-C6B1 after 3 days (a) AF4-fractogram with a light scattering (LS) signal and refractive
index (RI) signal as a function of elution time, for comparison: RI signal of G4-DS-C6B1 and avidin; (b) molar mass vs. elution time plot for the 1/1
ratio, (c) AF4-fractogramwith a light scattering (LS) signal and refractive index (RI) signal as a function of elution time, for comparison: RI signal of
G4-DS-C6B1 and avidin; (d) molar mass vs. elution time plot for the 1/3 ratio; the broken lines show the diﬀerent components found in the
superimposed peaks – free G4-DS and the conjugate of both bGD and avidin.
Table 5 Average molecular weights of the separated components in
the bio-hybrid associate avidin–G4-DS-C6B1 with a molar ratio of 1/1
and 1/3
Mn [g mol
1] Mw [g mol
1] Đa Part [%]
Molar ratio of avidin–G4-DS-C6B1 of 1/1
G4-DS-C6B1 50 100 57 100 1.02 21b
Avidin 66 600 67 400 1.01 20b
Avidin–G4-DS-C6B1 117 000 120 000 1.03 20b
Nanostructures 325 000 585 000 1.8 39b
Molar ratio of avidin–G4-DS-C6B1 1/3
G4-DSC6B1 50 100 57 100 1.01 35c
Avidin–G4-DS-C6B1 169 000 172 000 1.02 23c
Nanostructures 729 000 3 930 000 5.4 42c
a
Đ ¼ Mw/Mn represents the percentage of the nal composition by a
recovery of b77% and c59%.
Table 6 Average molecular weights of the single components by AF4
Mn [g mol
1] Mw [g mol
1] Đa Recovery [%]
Avidin 71 100 77 200 1.09 86
G4-DS 48 000 50 400 1.05 87
G4-DS-C6B1 50 100 57 100 1.14 80
G4-DS-PEG12B1 50 900 52 200 1.02 82
a
Đ ¼ Mw/Mn.
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LILBID-MS investigations where signals of the free bGD and free
avidin are also present in high intensities. The desired conju-
gates were indeed formed but even a higher molar ratio of 1/3
led only to the formation of 1/2 conjugates of avidin and G4-DS-
C6B1. This interesting fact could be proven by both methods
AF4 and LILBID MS. We also detected next to the desired
conjugate nanostructures (Fig. 11) which are characterized by
high molar masses and dispersities. Only an excess of multi-
valent bGD to avidin equivalents allows the fabrication of bio-
hybrid structures in a suﬃcient amount. This implies along
with the DLS and TEM results (Fig. 5) that longer biotin ligands
(e.g. PEG12B) or at least two short biotin ligands (C6B) attached
to the dendritic scaﬀold are necessary for the eﬃcient forma-
tion of the desired biohybrid structures.
Comparing our characterization results with the literature, the
characterization of previous supramolecular structures, based on
biotin–avidin conjugations and dendritic polymers, is directed to
HABA displacement assay, DLS and various chromatography
techniques only to identify the presence of successful formation
of biohybrid structures. But no further eﬀorts, e.g., by SLS, AF4, or
SAXS were undertaken to evaluate the molecular weight,
composition and shape of those dendritic supramolecular
structures initiated by avidin–biotin conjugation steps.
Experimental
Materials
Sodium tetraborate decahydrate, benzotriazole-1-yl-oxy-tris-
(dimethylamino)-phosphonium hexauorophosphate (BOP),
dimethylsulfoxide (DMSO), 6-(N-biotinylamino)caproic acid
(C6B), tris(hydroxymethyl)aminomethane (TRIS) and sodium
chloride (NaCl) were purchased from Sigma Aldrich. Hydrochloric
acid (Tritisol®) was purchased from Merck KGaA. Biotin-PEG12-
COOH (PEG12B) were obtained from Iris Biotech GmbH. Trieth-
ylamine (NEt3), D-(+)-maltose monohydrate, and borane–pyridine
complex (8 M in THF) (BH3$Pyr) were purchased from Fluka. 4th
generation poly(propylene imine) (PPI) dendrimer (DAB Am 64)
was supplied by SyMO-Chem (Eindhoven, Netherlands). Avidin
was purchased from Life Technologies (Darmstadt, Germany). All
chemicals were used as received. All photometric measurements
were performed in 1.5–3.0 mL PMMA cuvettes (PLASTIBRAND)
from Brand GmbH & Co. KG with a UV/Vis spectrophotometer DU
800 from Beckman Coulter GmbH. A 100 mM TRIS–HCl–0.1 M
NaCl solution with pH 7.5 was prepared by dissolving 6.72 g TRIS,
44 mL 1 N HCl and 5.84 g NaCl in 1 L MilliQ water.
Methods
1H NMR spectroscopy. The NMR experiments were per-
formed on a Bruker Avance III 500 NMR spectrometer operating
at 500.13 MHz for 1H NMR. DMSO-d6 or D2O was used as
solvent. The spectra recorded from DMSO-d6 solutions were
calibrated on the solvent signal (d(1H) ¼ 2.50 ppm). Spectra
recorded from D2O solutions were referenced on external
sodium 3-(trimethylsilyl)-3,3,2,2-tetradeuteropropionate in D2O
(d(1H) ¼ 0 ppm).
Infrared spectroscopy. The IR investigations were carried out
with a Bruker Vertex 80v spectrometer equipped with a heat able
Golden Gate Diamond ATR unit (SPECAC) and an MCT detector.
100 scans of the wavelength range 4000–600 cm1 per measure-
ment were carried out at a spectral resolution of 4 cm1.
Dynamic light scattering. To characterize the particle size
and size distribution, dynamic light scattering (DLS) measure-
ments were carried out at 25 C at a xed angle of 173 using the
Nano Zetasizer (Malvern), equipped with a He–Ne laser (4 mW)
and a digital autocorrelator. The observed data were analyzed
very carefully. Thus only measurements with a good t and an
exponential graphic representation were considered here. The
particle size distribution was determined using a multimodal
peak analysis by intensity, volume and number, respectively.
Solutions of the single components and of the biohybrid
structures were taken from HABA Displacement Assay.
Matrix-assisted laser desorption/ionization time of ight
mass spectrometry (MALDI-TOF MS). The MALDI-TOF experi-
ments were performed on an Autoex Speed TOF/TOF in a
reector mode and a positive polarity with 2,5-dihydroxybenzoic
acid as a matrix.
Laser-induced liquid bead ionization/desorption mass
spectrometry (LILBID-MS). LILBID-MS is a recently developed
method for the so mass spectrometric investigation of
biomolecules and biomolecular complexes.57,58 Liquid micro-
droplets of the aqueous uid sample (50 mL) are irradiated by
synchronized IR laser pulses (l ¼ 3 mm) generated by a home
built optical parametric oscillator (OPO) based on a LiNbO3
crystal and pumped by a commercial pulsed Nd-YAG laser. The
laser energy is absorbed by O–H stretch vibrations of water
molecules, which leads to the superexcitation and subsequent
explosive disruption of the droplet. The dendrimers injected
into vacuum were analysed by a TOF mass spectrometer. The
dendrimer samples (G4-DS-C6B1, G4-DS-C6B2, G4-DS-C6B4,
G4-DS-PEG12B1, G4-DS-PEG12B2 and G4-DS) were prepared in
aqueous solution at concentrations of 4  106 M. All
measurements were performed in anionic mode. LILBID-MS
was used to determine the molar masses of compounds G4-DS-
C6B1 and avidin and to study selected bioconjugates of avid-
in–G4-DS-C6B1 (5 mM/5 mM and 5 mM/20 mM) in 10 mM
TRIS–HCl pH 7.5 aer an incubation time of 24 h. The tech-
nique is described elsewhere.57 The experimental requirements
of LILBID-MS only allow TRIS–HCl buﬀer with decreased ionic
strength and without additional NaCl in comparison with the
buﬀer used in the DLS study.
UV/Vis spectroscopy. UV/Vis spectra were recorded at room
temperature (25 C) on a Varian Cary 50 UV/Vis spectrometer
(Varian Inc.). The slit width was 2 nm.
Spectrophotometric determination of avidin binding sites
with 2-(4-hydroxyazobenzene) benzoic acid.43 The estimation of
the avidin binding sites was determined according to the liter-
ature43 by titration experiments of avidin with a starting
concentration co ¼ 10.1 mM with a solution of the azo dye HABA
(2-(4-hydroxyazobenzene) benzoic acid) with a concentration
ct ¼ 0.3 mM. The avidin solution was titrated with appropriate
amounts of a concentrated biotinylated macromolecule
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solution in 0.1 M TRIS–HCl buﬀer with 0.1 M NaCl at pH 7.4. At
the end of the titration, the titrated solution was diluted by
approximately 70% of the starting volume. The resulting spec-
trum for each titration step was corrected by the appropriate
dilution factor. Every titration experiment revealed the specic
activity of avidin as specied by the supplier.
HABA displacement titrations – spectrophotometric deter-
mination of avidin binding capacity with biotin and its
analogs.43 The titration experiments of the HABA–avidin
complex were carried out with biotin (ct ¼ 0.185 mM), G4-DS
(ct ¼ 0.15 mM), G4-DS-C6B1 (ct ¼ 0.15 mM), G4-DS-C6B2 (ct ¼
0.15 mM), G4-DS-C6B4 (ct ¼ 0.15 mM), G4-DS-PEG12B1 (ct ¼
0.15 mM), G4-DS-PEG12B2 (ct ¼ 0.15 mM) and G4-DS-PEG12B4
(ct¼ 0.15 mM) in a 3-fold determination in disposable sizing UV
microcuvettes. Therefore the solution (HABA–avidin complex;
cavidin ¼ 10.1 mM and cHABA ¼ 16  cavidin to ensure fast satu-
ration of the avidin binding sites by the azo dye HABA) was
titrated with appropriate amounts of a concentrated bio-
tinylated macromolecule solution in 0.1 M TRIS–HCl buﬀer
with 0.1 MNaCl at pH 7.4. At the end of the titration, the titrated
solution was diluted by approximately 70% of the starting
volume. The resulting spectrum for each titration step was
corrected by the appropriate dilution factor. This procedure was
also used to determine the degree of biotin ligand functionali-
zation through regression of the two linear regions of the curves
before and aer the equivalence point (Fig. 4).
HABA displacement assay for UV/Vis observation of the
formation processes for the diﬀerent biohybrid structures. A
HABA–avidin solution with an avidin concentration of 1 mg
mL1 was prepared with a 16-fold excess of HABA to avidin. This
solution was converted with a biotinylated compound. The nal
avidin concentration was 6.25 mM within all samples. The
resulting bioconjugates were measured by UV/Vis spectroscopy
aer 24 h. The dynamic light scattering measurements were
carried out aer 1 or as indicated in the main part 7 days.
Determination of bound biotinylated glycodendrimer to
avidin. To determine the apparent amount of coupled bio-
tinylated glycodendrimer to avidin the measured absorbance
values at 500 nm of the avidin–biotinylated glycodendrimer
mixtures and the linear regression of the lower part of the
titration curves were used to calculate the related amount of
biotinylated glycodendrimer coupled to avidin.
Asymmetrical ow eld ow fractionation. The AF4 instru-
ment was an Eclipse 3 Separation System (Wyatt Technology
Europe, Germany). The ow was controlled with an isocratic
pump (1200 Series from Agilent Technologies, USA) and all
injections were performedwith an autosampler (1200 Series from
Agilent Technologies, USA). A long AF4-channel (Wyatt Tech-
nology Europe, Germany) having a tip-to-tip length of 26.65 cm
and a nominal thickness of 490 mmwas used. The ultra-ltration
membrane forming the accumulation wall was made of regen-
erated cellulose with a molecular weight cut oﬀ of 10 kDa (Wyatt
Technology Europe, Germany). The detection system consists of a
multi-angle laser light scattering detector (DAWN EOS from
Wyatt Technology Europe, Germany) operating at a wavelength of
690 nm and a refractive index detector (Dn 2010 from WGE Dr
Bures, Germany) operating at a wavelength of 620 nm. Carrier
liquid was prepared with 0.1 M TRIS–HCl (Sigma-Aldrich, Ger-
many), 0.1 M NaCl (Carl Roth, Germany) and 0.02% (w/v) NaN3
(Carl Roth, Germany) dissolved in pure water, which was deion-
ised, UV treated and ultra-ltered using Purelab Plus UV/UF
equipment (ELGA LabWater, Germany).
The sample injection of 100 mL into the channel was per-
formed at a ow rate of 0.2 mL min1 for 2 min. The sample
load was approximately 100–150 mg. Separation and determi-
nation of the molecular weight of the sample were performed
aer focusing at 3 mL min1 over a period of 2 min and elution
with a linearly decaying cross ow from 3 mL min1 to 0 mL
min1 in 15 min and aerwards without any cross ow for
10 min. The detector ow rate was constant at 1 mL min1
throughout the measurement. Two measurements of each
sample were carried out. Aerwards a blank run was performed
for the baseline subtraction of the pressure sensitive signal of
the refractive index detector.
Collecting and processing of detector data were made by the
Astra soware, version 5.3.4.20 (Wyatt Technology, USA). The
molar mass dependence of the elution volume was tted with
4th degree exponential. For Mw determination the dn/dc values
were externally determined at 25 C using the refractive index
detector of the system. The refractive index increments, dn/dc of
0.174 mL g1 for avidin, 0.149 mL g1 for G4-DS, 0.159 mL g1
for G4-DS-C6B1, 0.162 mL g1 for G4-DS-C6B1, and 0.160 mL
g1 for the avidin–G4-DS-C6B1 associates (at diﬀerent molar
ratios), were determined for the light scattering calculations.
Transmission electron microscopy. The morphology and
size of the particles were determined by transmission electron
microscopy with the Libra 120 (Carl Zeiss AG, Oberkochen,
Germany) along with the dynamic light scattering measure-
ments. Samples were prepared by dropping sample solutions
with an increased concentration of 2 mg mL1 and a decreased
molarity of the buﬀer (10 mM) on carbon coated gold grids. The
air dried samples were examined in the transmission electron
microscope at an acceleration voltage of 120 kV.
Purication of conjugation solution with G4-DS-PEG12B2
with 1/1 molar ratio. 5.4 mL of an equimolar solution of G4-DS-
PEG12B2 and avidin (2.19  105 M) in TRIS–HCl–NaCl 0.1 M
was equilibrated for 24 h. The resulting solution was diluted up
to approximately 35 mL and subsequently ltered with a mPES
membrane of 300 kDa for up to 100 mL with an approximate
pressure of 200 mbar and a volume ow of 15 mL s1. Every
20 mL of the sample obtained by the ltration procedure was
taken for DLS measurements. The hollow bre ltration
method was done by using the KrosFlo-Research-IIi (Spec-
trumLabs, USA), equipped with a polysulfone-based separation
module (MWCO: 300 kDa, SpectrumLabs, USA).
Synthesis of compounds
General procedure for the synthesis of the precursor
G4-C6Bx, G4-PEG12Bx, x ¼ 1, 2 and 4. 4th generation PPI den-
drimer (G4, 7168 g mol1; considering footnote i in paper), 6-(N-
biotinylamino)caproic acid (C6B, 357.47 g mol1) or biotin-PEG12-
COOH (PEG12B, 844.0 g mol1), benzotriazole-1-yl-oxy-tris-
(dimethylamino)-phosphonium hexauorophosphate (BOP,
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442.28 g mol1) and triethylamine (Et3N, 0.73 g mL
1, 101.19 g
mol1) were taken up in DMSO (10 mL). The solution was stirred
at room temperature for 2 days. The crude product was puried by
dialysis in deionized water for 2 days. A yellowish viscous
substance was obtained by freeze drying. The product was yielded
quantitatively as a solid. The molar ratios for both conversion
steps are summarized in Table 7 and Table 8, respectively.
G4-C6Bx or G4-PEG12Bx, x ¼ 1, 2 or 4.
G4-C6Bx (x ¼ 1, 2 or 4). 1H NMR (D2O): 4.60 (10), 4.41 (9), 3.32
(12), 3.2–2.3 (18, b,c,e,f,h,I,k,l,n,o,q of IIb), 2.89 (q of I), 2.99 and
2.78 (11), 2.24 (16,22), 1.9–1.6 (1H of 13,a,d,g,j,m,p), 1.6–1.25 ppm
(1H of 13,14,15,19-21). Free ligand (–COOH): 1.55 (21), 2.17 (22)
(Fig. ESI-1†); IR: 3298 (NH2), 2865 (CH, CH2), 2802 (CH, CH2),
1646 (C]O), 1566 (N–H, NH2), 1384 (CH2, CH3) 1009 cm
1 (C–O).
G4-PEG12Bx (x ¼ 1, 2 or 4). 1H NMR (D2O): 4.60 (10), 4.41 (9),
3.77 (21), 3.69 (20), 3.62 (19), 3.38 (18), 3.33 (12), 3.3–2.3
(b,c,e,f,h,I,k,l,n,o,q of IIb), 2.93 (q of I), 2.99 and 2.78 (11), 2.52
(22), 2.27 (16), 1.9–1.6 (1H of 13, a,d,g,j,m,p), 1.6–1.35 ppm (1H
of 13,14,15) (Fig. 3a). Free ligand (–COOH): 3.73 (21), 2.45 (22)
(Fig. 3a); IR: 3305 (NH2), 2870 (CH, CH2), 2802 (CH, CH2), 1646
(C]O), 1566 (N–H, NH2), 1384 (CH2, CH3) 1010 cm
1 (C–O).
General procedure for the synthesis of the maltose modied
dense shell glycodendrimers. The precursor, maltose mono-
hydrate (360.31 g mol1) and borane–pyridine complex
(BH3  Pyr, 8 M) were taken up in a sodium borate buﬀer
(25 mL, 0.1 M). The solution was stirred at 50 C for 7 days. The
crude product was puried twice by dialysis with deionized
water for 4 days to ensure the capture of impurities. The solid
product was obtained by freeze drying. The molar ratios and
yields for the conversion steps are summarized in Table 8.
G4-DS.
1H NMR: (D2O). Signal assignment according to B. Klajnert
and D. Appelhans et al., Chem. Eur. J., 2008, 14, 7030–7041.41
G4-DS-C6Bx (x ¼ 1, 2 or 4). 1H NMR (D2O): 5.4–5.0 (1),
4.60 (10), 4.43 (9), 4.4–3.3 (2-6,20-60,12), 3.3–2.2
(10,11,16,18,22,b,c,e,f,h,I,k,l,n,o,q), 2.2–1.1 ppm (13-15,19-
21,a,d,g,j,m,p) (Fig. ESI-2†); IR: 3298 (NH2), 2865 (CH, CH2),
Table 7 Molar ratio and molecular weight of the educts for the precursor synthesis
Precursor
G4,
eq. [mol] [mg]
C6B,
eq. [mol] [mg]
PEG12B,
eq. [mol] [mg]
BOP,
eq. [mol] [mg]
NEt3,
eq. [mol] [mL]
G4-C6B1 1.0 1.1 — 2.5 10.0
1.395  105 1.535  105 3.488  105 1.395  104
100.0 5.5 15.5 0.019
G4-C6B2 1.0 2.2 — 5.0 20.0
1.395  105 1.535  105 6.975  105 2.790  104
100.0 11.0 31.0 0.038
G4-C6B4 1.0 4.4 — 11.0 20.0
1.395  105 1.535  105 16.89  105 2.790  104
100.0 22.0 62.0 0.038
G4-PEG12B1 1.0 — 1.1 5.0 10.0
1.395  105 1.535  105 6.975  105 1.395  104
100.0 13.0 31.0 0.019
G4-PEG12B2 1.0 — 2.2 10.0 20.0
1.395  105 1.535  105 13.95  105 2.790  104
100.0 26.0 62.0 0.038
G4-PEG12B4 1.0 — 4.4 8.8 20.0
1.395  105 3.07  105 13.95  105 2.790  104
100.0 52.0 54.6 0.038
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2802 (CH, CH2), 1646 (C]O), 1566 (N–H, NH2), 1384 (CH2, CH3)
1009 cm1 (C–O); LILBID MS: G4-DS-C6B1 (45 900 g mol1 118
maltose units and 1 C6Bmoiety connected to PPI-G4);m/z¼ top
of the peak of about 46 000 (M) (Fig. ESI-4b†). The number of
maltose units in G4-DS-C6B1 was calculated by LILBID MS and
conrmed from the 1H NMR spectrum recorded in D2O taking
into account the degree of biotin functionalization determined
through HABA displacement titrations (Fig. 4 and Table 1). G4-
DS-C6B2: m/z ¼ 46 100 (M) (Fig. ESI-5a†), G4-DS-C6B4: m/z ¼
47 650 g mol1 (M) (Fig. ESI-6b†).
G4-DS-PEG12Bx (x ¼ 1, 2 or 4). 1H NMR (D2O): 5.4–5.0 (1),
4.60 (10), 4.43 (9), 4.4–3.3 (2-6,20-60,12,18,19,21), 3.70 (20), 3.3–
2.2 (10,11,12,16,22,b,c,e,f,h,I,k,l,n,o,q), 2,27 (16), 2.2–1.1
(13-15,a,d,g,j,m,p) (Fig. 3b); IR: 3305 (NH2), 2870 (CH, CH2),
2802 (CH, CH2), 1646 (C]O), 1566 (N–H, NH2), 1384 (CH2, CH3)
1010 (C–O); LILBID MS: G4-DS-PEG12B1 m/z ¼ 45 900 (M)
(Fig. ESI-5b†).G4-DS-PEG12B2:m/z¼ 45 700 (M) (Fig. ESI-6a†);
G4-DS-PEG12B4: M ¼ 43 750 g mol1 (determined by 1H NMR
approach41).
Conclusion
We have demonstrated the successful fabrication of biohybrid
structures tailored by non-covalent interactions. Using avidin–
biotin conjugation as the deciding non-covalent interaction
step, diﬀerent nanometer-sized biohybrid structures can be
established by using diﬀerent molar interaction ratios between
mono-, bi- and tetravalent biotinylated glycodendrimers (bGD)
and avidin, shortly summarized in Fig. 9. Furthermore, these
biohybrid structures were comprehensively analysed by
diﬀerent complementary methods such as DLS, UV/Vis and
TEM. Moreover LILBID-MS and AF4 investigations for rst
dened molar interaction ratios (1/1 and 3/1) between
monovalent bGD with the short C6B ligand and avidin gave
interesting new insights, that at least two key factors (type of
biotinylation and higher ligand–receptor stoichiometries) are really
important in the formation of desired biohybrid structures by
inducing the necessary avidin–biotin conjugations.
This study clearly emphasized how the size dimension of the
biohybrid structures can be controlled by diﬀerent key factors.
Controlling the maximal size dimensions of the biohybrid
structures up to 100 nm is given by the interplay of two key
factors: degree of biotinylation on the dendritic glycosurface
needs 4 biotin ligands, and dened ligand–receptor stoichiome-
tries, even more preferring minor or equimolar bGD.
Moreover, the quality of biotin ligand functionalization (e.g.
length and chemical nature of the spacer or the number of
coupled biotin ligands) on the dendritic glycosurface is a pivotal
aspect in the ne-tuning in order to fabricate biohybrid nano-
structures with tailored characteristics. Preferentially estab-
lishing avidin as a central unit in the nanostructures, the longer
PEG12B ligand in monovalent bGD proved to be the more
eﬀective in the bioconjugation strategy than the shorter C6B
ligand.
Overall the fabrication of (complex) biohybrid structures by a
simultaneous approach is possible. Here, the dened ligand–
receptor stoichiometries give us the possibility to tune the size
dimensions of the biohybrid structures (<20, <30 or up to 100
nm). This study further implies that a higher number of biotin
ligands (>4 biotin ligands) in glycodendrimer macromolecules
in the biohybrid structure fabrication approach will immedi-
ately result in stronger aggregation and/or depolymerisation
steps depending on the use of ligand–receptor stoichiometry.
Generally, the fabrication of biohybrid structures is tailored by
inter- and intramolecular association and dissociation steps
until nal sizes of the supramolecular structures are achieved.
Table 8 Molar ratio and molecular weight of the precursors for the glycodendrimer synthesis and overall yield
Glycodendrimer
Precursor, Mn,
eq. [mol] [mg]
Maltose,
eq. [mol] [mg]
BH3  Pyr,
eq. [mol] [mL] Yield, [%]
G4-DS G4, 7168 g mol1 1.0 1280.0 1280.0 94
1.395  105 17.86  103 17.86  103
100.0 6.44 2.24
G4-DS-C6B1 G4-C6B1, 7500 g mol1 1.0 1280.0 1280.0 95
1.379  105 17.65  103 17.65  103
105.0 6.36 2.22
G4-DS-C6B2 G4-C6B2, 7850 g mol1 1.0 1280.0 1280.0 92
1.388  105 17.77  103 17.77  103
109.0 6.40 2.24
G4-DS-C6B4 G4-C6B4, 8500 g mol1 1.0 1280.0 1280.0 96
1.282  105 16.41  103 16.41  103
109.0 5.91 2.07
G4-DS-PEG12B1 G4-PEG12B1, 8000 g mol1 1.0 1280.0 1280.0 93
1.377  105 17.63  103 17.63  103
110.2 6.35 2.22
G4-DS-PEG12B2 G4-PEG12B2, 8820 g mol1 1.0 1280.0 1280.0 95
1.385  105 17.73  103 17.73  103
122.2 6.39 2.23
G4-DS-PEG12B4 G4-PEG12B4, 10 500 g mol1 1.0 1280.0 1280.0 92
0.842  105 10.78  103 10.78  103
88.4 6.39 1.36
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However, the next challenge will be the integration of separa-
tionmethods (dialysis, hollow ber ltration or AF4) to separate
non-biotinylated and non-conjugated macromolecules or
smaller hybrid structures from larger supramolecular structures
in a more intense fashion as a next step for the preparation of
more dened biohybrid structures for biomedical applications.
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